Impact of Maternal Asthma and Asthma Treatment During Pregnancy on Neurodevelopmental Outcomes: Findings from a Cohort Study of 179,024 Children - Takeaways - MDSpire

Impact of Maternal Asthma and Asthma Treatment During Pregnancy on Neurodevelopmental Outcomes: Findings from a Cohort Study of 179,024 Children

  • By

  • Lama A. Shakhshir

  • Sarjit Singh

  • Jill P. Pell

  • Scott M. Nelson

  • Daniel F. Mackay

  • Claire E. Hastie

  • Logesh R. Sivakumar

  • Michael Fleming

  • February 20, 2026

  • 0 min

Share

  • 1

    Asthma affects 8–13% of pregnant women, necessitating continued medication to mitigate risks to maternal and fetal health.

  • 2

    The study analyzed 179,024 children to assess the impact of maternal asthma and medication on neurodevelopmental outcomes.

  • 3

    Findings indicated inconsistent associations between maternal asthma treatment and neurodevelopmental issues like ASD and ADHD.

  • 4

    The cohort included children born in Wales from 2009 to 2016, with 12.4% having mothers with asthma or asthma medication.

  • 5

    The research highlights the need for further investigation into the long-term neurodevelopmental effects of asthma treatments during pregnancy.

Original Source(s)

Impact of Maternal Asthma and Asthma Treatment During Pregnancy on Neurodevelopmental Outcomes: Findings from a Cohort Study of 179,024 Children

  • by Lama A. Shakhshir, Sarjit Singh, Jill P. Pell, Scott M. Nelson, Daniel F. Mackay, Claire E. Hastie, Logesh R. Sivakumar, Michael Fleming

  • February 20, 2026

Related Content

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

AI Falls Short on Differential Dx

New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models

Casey Means, a MAHA leader, makes bid to be nation’s top doctor